Loading…
Oragenics, Inc. is projected to rise to $0.6689 by 2027, a +14% move from its current price of $0.589. OGEN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.5709 | $0.5889 | $0.6075 | -0.01% |
| May 30 | $0.5636 | $0.5889 | $0.6153 | -0.02% |
| May 31 | $0.558 | $0.5888 | $0.6213 | -0.04% |
| Jun 1 | $0.5533 | $0.5887 | $0.6264 | -0.05% |
| Jun 2 | $0.5492 | $0.5887 | $0.631 | -0.06% |
| Jun 3 | $0.5455 | $0.5886 | $0.6351 | -0.07% |
| Jun 4 | $0.5421 | $0.5885 | $0.6389 | -0.08% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.5421 | $0.5885 | $0.6389 | -0.08% |
| Week 2 | $0.5235 | $0.588 | $0.6605 | -0.17% |
| Week 3 | $0.5096 | $0.5875 | $0.6774 | -0.25% |
| Week 4 | $0.4981 | $0.587 | $0.6919 | -0.33% |
| Week 5 | $0.4881 | $0.5866 | $0.7049 | -0.42% |
| Week 6 | $0.4792 | $0.5861 | $0.7167 | -0.50% |
| Week 7 | $0.4712 | $0.5856 | $0.7278 | -0.58% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Oragenics, Inc. is a development-stage healthcare company focused on research and development of nasal delivery pharmaceutical therapies for neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury.
Oragenics, Inc. was incorporated in 1996 and is headquartered in Lakewood Ranch, Florida. It was formerly known as Oragen, Inc.
Oragenics, Inc. (OGEN) is trading at $0.597 with a market capitalization of $2.69M, and it is ranked 5448 by market cap. The current price sits within a broader equity position that is reflected in a modest market footprint.
The near-term outlook remains neutral, with forecast data showing a 2026 average price of $0.597 and a 30-day trading range of $0.4803 to $0.742.
Looking further out, the forecast turns bullish from 2032 onward, with rising averages and ROIs culminating in a 2050 average of $1.80 and an ROI of 202.2%. Near-term technical levels place support at $0.56 and resistance at $0.72, anchoring the price action through the forecast horizon.
A major floor 21.3% below — a decisive break under it would weaken the trend.
The nearest floor, 4.9% below — buyers have tended to step in here.
The nearest ceiling, 22.2% above — a clean break opens room to run.
A major ceiling 68.1% above — clearing it would confirm fresh momentum.
Key OGEN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OGEN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.59 | Sell | $0.589 | Buy |
| MA 10 | $0.582 | Buy | $0.5887 | Buy |
| MA 20 | $0.5935 | Sell | $0.5975 | Sell |
| MA 50 | $0.6222 | Sell | $0.6411 | Sell |
| MA 100 | $0.7219 | Sell | $0.7817 | Sell |
| MA 200 | $0.9194 | Sell | $2.25 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.06 | Neutral |
| Stoch RSI (14) | 81.32 | Sell |
| CCI (20) | -14.40 | Neutral |
| Williams %R (14) | -40.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -1.67 | Sell |
| Bollinger %B (20,2) | 0.46 | Neutral |
| Stochastic %K (14) | 60.00 | Neutral |
| TRIX (15) | -0.42 | Sell |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 46.38 | Neutral |
| Momentum (10) | 0.00 | Neutral |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 0.60 | Sell |
| ADX (14) | 12.41 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is NEUTRAL with an RSI14 of 50. The 50-day simple moving average is $0.6324 and the 200-day simple moving average is $0.9258. Key near-term levels show support at $0.56 and resistance at $0.72. The 30-day price range spans from $0.4803 to $0.742, highlighting a relatively tight trading band in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.50 | $0.589 | $0.8112 | 0% | Neutral | |
| $0.5234 | $0.6689 | $0.9096 | +14% | Neutral | |
| $0.516 | $0.6803 | $0.9627 | +16% | Neutral | |
| $0.462 | $0.6255 | $0.9133 | +6% | Neutral | |
| $0.4321 | $0.5989 | $0.8979 | +2% | Neutral | |
| $0.4461 | $0.6318 | $0.9694 | +7% | Neutral | |
| $0.5285 | $0.7636 | $1.20 | +30% | Bullish | |
| $0.5672 | $0.8351 | $1.33 | +42% | Bullish | |
| $0.5183 | $0.777 | $1.26 | +32% | Bullish | |
| $0.5244 | $0.80 | $1.32 | +36% | Bullish | |
| $0.6387 | $1.05 | $1.86 | +79% | Bullish | |
| $0.9318 | $1.77 | $3.44 | +200% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.50 | $0.589 | $0.6946 | +0.00% |
| June 2026 | $0.4974 | $0.5859 | $0.7078 | -0.53% |
| July 2026 | $0.4899 | $0.5827 | $0.7147 | -0.55% |
| August 2026 | $0.5067 | $0.6072 | $0.7535 | +4.21% |
| September 2026 | $0.5087 | $0.6133 | $0.7684 | +1.01% |
| October 2026 | $0.4901 | $0.5943 | $0.751 | -3.10% |
| November 2026 | $0.4945 | $0.6026 | $0.7673 | +1.40% |
| December 2026 | $0.5166 | $0.6327 | $0.8112 | +4.99% |
Click any year to see its month-by-month OGEN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Oragenics, Inc.'s 2026 outlook centres on $0.589, within a $0.50 to $0.8112 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, OGEN could reach as high as $0.9096, with a base case around $0.6689 and support toward $0.5234 — roughly +14% from $0.589. A consolidation phase looks the most probable path here.
Expect OGEN to range from $0.516 to $0.9627 through 2028. The $0.6803 average target implies a +16% move from current prices. That is up +2% on the projected 2027 average. Price action looks broadly range-bound.
The OGEN price prediction for 2029 points to an average of $0.6255 (low $0.462, high $0.9133) — a potential gain of +6% on today's $0.589. A consolidation phase looks the most probable path here.
In 2030, OGEN is projected to trade between $0.4321 and $0.8979, averaging $0.5989 — a potential gain of +2% from today's $0.589. That is -4% versus the projected 2029 average. Price action looks broadly range-bound.
Oragenics, Inc.'s 2031 outlook centres on $0.6318, within a $0.4461 to $0.9694 range. That is up +5% on the projected 2030 average. That marks a +7% change versus current levels. A consolidation phase looks the most probable path here.
By 2032, OGEN could reach as high as $1.20, with a base case around $0.7636 and support toward $0.5285 — roughly +30% from $0.589. Momentum favours further upside here.
Expect OGEN to range from $0.5672 to $1.33 through 2033. The $0.8351 average target implies a +42% move from current prices. That is up +9% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The OGEN price prediction for 2034 points to an average of $0.777 (low $0.5183, high $1.26) — a potential gain of +32% on today's $0.589. Momentum favours further upside here.
In 2035, OGEN is projected to trade between $0.5244 and $1.32, averaging $0.80 — a potential gain of +36% from today's $0.589. That is up +3% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Oragenics, Inc.'s 2040 outlook centres on $1.05, within a $0.6387 to $1.86 range. That is up +32% on the projected 2035 average. That marks a +79% change versus current levels. Momentum favours further upside here.
By 2050, OGEN could reach as high as $3.44, with a base case around $1.77 and support toward $0.9318 — roughly +200% from $0.589. Buyers look set to stay in control over this stretch.
Investing $1,000 in OGEN today (≈ 1,697.792869 OGEN) could be worth
$3,004.29
+$2,004.29 (+200%) by 2050 · US Dollar
Based on the average projected OGEN price of $1.77 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OGENwould be worth at today's price.
$1,000 invested in OGEN on May 27, 2025 (≈ 175.438602 OGEN) would be worth
$103.33
-$896.67 (-89.7%) today · 0.10× · US Dollar
Based on a OGEN entry price of $5.7 vs. today's $0.589.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.58 | $1,015.52 | +1.6% |
| 1 month ago | $0.63 | $934.92 | -6.5% |
| 3 months ago | $0.88 | $669.32 | -33.1% |
| 6 months ago | $0.87 | $677.01 | -32.3% |
| 1 year ago | $5.7 | $103.33 | -89.7% |
| All time (5.0y) ago | $1,260 | $0.47 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OGEN forecast.
Our base-case forecast reaches $1.20 around 2050.
Implied market cap at $1.20: $5.41M
In 2026 the min is $0.50, the avg is $0.597, the max is $0.8353, and the ROI is 0%. The sentiment is NEUTRAL. In 2027 the min is $0.5268, the avg is $0.6783, the max is $0.9315, and the ROI is 13.6% with a NEUTRAL sentiment.
In 2028 the min is $0.5233, the avg is $0.6967, the max is $0.9975, and the ROI is 16.7% with a NEUTRAL sentiment. In 2029 the min is $0.4617, the avg is $0.6322, the max is $0.9354, and the ROI is 5.9% with a NEUTRAL sentiment. In 2030 the min is $0.4257, the avg is $0.5978, the max is $0.9093, and the ROI is 0.1% with a NEUTRAL sentiment.
In 2031 the min is $0.4487, the avg is $0.6449, the max is $1.00, and the ROI is 8% with a NEUTRAL sentiment. In 2032 the min is $0.5304, the avg is $0.7791, the max is $1.24, and the ROI is 30.5% with a BULLISH sentiment. In 2033 the min is $0.5645, the avg is $0.8463, the max is $1.37, and the ROI is 41.8% with a BULLISH sentiment.
In 2034 the min is $0.5195, the avg is $0.7941, the max is $1.31, and the ROI is 33% with a BULLISH sentiment. In 2035 the min is $0.5211, the avg is $0.8117, the max is $1.36, and the ROI is 36% with a BULLISH sentiment. In 2040 the min is $0.6343, the avg is $1.08, the max is $1.94, and the ROI is 80.4% with a BULLISH sentiment.
In 2050 the min is $0.9113, the avg is $1.80, the max is $3.60, and the ROI is 202.2% with a BULLISH sentiment.
Tap a question to reveal the answer.
According to the forecast, in 2030 the expected range is min $0.4257, avg $0.5978, max $0.9093, with ROI 0.1% and NEUTRAL sentiment.
Forecasts show a NEUTRAL sentiment through 2031, with higher ROIs emerging from 2032 onward and a 2050 average of $1.80 with ROI 202.2%, indicating a wide range of potential outcomes rather than a guaranteed path.
Yes. The 2031 forecast lists a max of $1.00, with an average of $0.6449, a min of $0.4487, and ROI 8% under NEUTRAL sentiment.
The 2050 forecast shows an avg of $1.80, a max of $3.60, a min of $0.9113, and ROI of 202.2% with a BULLISH sentiment.
The near-term picture features NEUTRAL sentiment, RSI 14 of 50, SMA50 of $0.6324, SMA200 of $0.9258, with support at $0.56 and resistance at $0.72. The 30-day range is $0.4803 to $0.742, and annualized volatility is 60%.
Oragenics, Inc. Community Discussion
0Share your Oragenics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.